Login to Your Account



Clinic Roundup


Monday, October 22, 2012

• Histogen Inc., of San Diego, said preliminary data from an ongoing Phase I/II study showed that its Hair Stimulating Complex (HSC) produced statistically significant improvement across all targeted hair growth parameters, with an 86 percent responder rate. The study tested HSC in 56 men with androgenetic alopecia and also was well tolerated, with no study-related adverse events reported. Data were presented at the International Society of Hair Restoration Surgery meeting in the Bahamas.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription